Pages that link to "Q38446601"
Jump to navigation
Jump to search
The following pages link to Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. (Q38446601):
Displaying 50 items.
- Tumor metastasis to bone (Q21195416) (← links)
- The beta-catenin binding protein ICAT modulates androgen receptor activity (Q24337124) (← links)
- Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression (Q26773413) (← links)
- Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications (Q28076060) (← links)
- Cellular Plasticity in Prostate Cancer Bone Metastasis (Q28085013) (← links)
- Wnt/β-catenin signalling in prostate cancer (Q28269116) (← links)
- PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer (Q28292541) (← links)
- The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability (Q28396729) (← links)
- Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome (Q28477590) (← links)
- Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis (Q28480423) (← links)
- Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation (Q28575953) (← links)
- Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling (Q28586334) (← links)
- ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer (Q28771736) (← links)
- Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting. (Q30409623) (← links)
- Prostate cancer invasion and metastasis: insights from mining genomic data (Q30656758) (← links)
- BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo (Q33295288) (← links)
- The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens (Q33316388) (← links)
- Regulation of epithelial branching morphogenesis and cancer cell growth of the prostate by Wnt signaling (Q33334385) (← links)
- Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity (Q33611142) (← links)
- Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment (Q33622608) (← links)
- Inhibition of cancer cell migration and invasion through suppressing the Wnt1-mediating signal pathway by G-quadruplex structure stabilizers (Q33652068) (← links)
- Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial (Q33717507) (← links)
- Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells (Q33902551) (← links)
- Androgen Receptor-dependent Expression of Low-density Lipoprotein Receptor-related Protein 6 is Necessary for Prostate Cancer Cell Proliferation (Q34043947) (← links)
- Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells (Q34126555) (← links)
- Examining the Metastatic Niche: Targeting the Microenvironment (Q34152023) (← links)
- Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases (Q34511164) (← links)
- β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma (Q34539930) (← links)
- A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. (Q34550256) (← links)
- The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. (Q34612838) (← links)
- The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis (Q34699785) (← links)
- Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling (Q34706869) (← links)
- Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. (Q34959208) (← links)
- A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer (Q34999463) (← links)
- Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells (Q35199287) (← links)
- Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo (Q35243349) (← links)
- Potential of Mesenchymal Stem Cell based application in Cancer (Q35540034) (← links)
- Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype (Q35550094) (← links)
- Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer (Q35572195) (← links)
- Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration (Q35624078) (← links)
- A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice (Q35755034) (← links)
- Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells (Q35823999) (← links)
- Osteoblasts in prostate cancer metastasis to bone (Q35998759) (← links)
- Wnt signalling and prostate cancer (Q36089054) (← links)
- PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor. (Q36143607) (← links)
- Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies (Q36272854) (← links)
- Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells (Q36303639) (← links)
- Genomics of prostate cancer: is there anything to "translate"? (Q36358322) (← links)
- Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression (Q36796016) (← links)
- Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system (Q36815379) (← links)